Optellum is a commercial-stage lung health company providing Artificial Intelligence decision support software that assists physicians in early diagnosis and optimal treatment for their patients. We want every lung disease patient to be diagnosed and treated at the earliest possible stage, when chances of cure are the highest. Optellum’s roadmap extends beyond lung cancer diagnosis and treatment to other deadly diseases of the lungs, including interstitial lung disease and chronic obstructive pulmonary disease.
Northwestern Medicine Canning Thoracic Institute
Northwestern Medicine Canning Thoracic Institute is among the top-ranked for pulmonology and lung surgery.
Nordic Bioscience A/S
Nordic Bioscience is a Danish biomarker company headquartered in Herlev, Denmark. Nordic Bioscience is engaged in biomarker development using our unique neoepitope technology. We combine our expertise in biomarker development with preclinical and clinical research. This enables us to develop biomarkers that provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting.
Noah Medical
Noah Medical operates with patients and physicians as our focus. We’re building cutting-edge medical technologies to enable providers to treat patients early and save lives while leaving minimal scars behind.
MERIT
MERIT has provided image collection, centralized reading, and data management services for clinical trials since 2012. Through innovative and proven technologies, alongside our intuitive, seamless workflows, MERIT’s experienced staff bring more than a decade of clinical endpoint expertise, ensuring the success and integrity of your clinical trials. Our team has managed 100+ oncology studies across 20+ cancer types. MERIT values your partnership and will make your study a priority! Connect with us by email at oncology@meritcro.com or call (608) 509-7122. | MERIT provides reliable and attentive expertise for your clinical trial endpoint analysis. We specialize in respiratory studies, offering agile centralized spirometry expertise. MERIT has a proven track record providing endpoint expertise to 12 of the top 20 global pharma companies. We conduct studies across the globe, supporting sites in 63 countries. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn. | Verona Pharma is a subsidiary of Merck& Co, Inc.,(Rahway, New Jersey, USA). For more information, please visit www.veronapharma.com. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. | We aspire to be the premier research-intensive biopharmaceutical company | We aspire to be the premier research-intensive biopharmaceutical company. Our purpose: We use the power of leading-edge science to help save and improve lives around the world For more than 130 years, and since 1911 in Canada, Merck has brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Medtronic
Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. | We lead global healthcare technology. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people. Transforming the lives of two people every second, every hour, every day. Medtronic. | We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us. Medtronic. Engineering the extraordinary. | We lead global healthcare technology. Our Mission: to alleviate pain, restore health, & extend life, unites a global team of people. Transforming the lives of two people every second, every hour, every day. Medtronic. Engineering the extraordinary. | edtronic is a global leader in medical technology dedicated to improving healthcare and transforming patient outcomes through innovation and collaboration. Through its technologies, the Coronary and Renal Denervation operating unit seeks to improve health for the one billion people living with high blood pressure globally, and the 315 million people living with coronary artery disease around the world. | Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission – to alleviate pain, restore health, and extend life – unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second.
Median Technologies
Median Technologies is pioneering next-generation software as a medical device and imaging services, leveraging advanced AI to improve the precision of cancer early diagnosis and treatment. Our offerings feature iCRO, providing central imaging services and AI based image analysis for oncology trials, and eyonis®, an AI/ML-powered suite of Software as a Medical Device (SaMD). We empower biopharma companies and clinicians to accelerate the development of innovative therapies and elevate patient care. Headquartered in France with operations in the U.S. and China, Median Technologies is listed on Euronext Growth. | A pioneer in applying artificial intelligence technologies to medical imaging, Median Technologies develops and markets eyonis® — a suite of AI-powered Software as a Medical Device for the early diagnosis of solid tumor cancers. The first device of the eyonis® portfolio, eyonis® LCS, is designed for lung cancer screening procedures. eyonis® LCS is currently under review for FDA 510(k) clearance in the U.S. and CE marking in Europe. In addition to its Software as a Medical Device business, Median also provides central imaging services and AI-based image analysis for oncology clinical trials in the biopharmaceutical industry through its iCRO business.
Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. We harness our deep expertise in surgery, orthopedics, vision, and interventional solutions to design healthcare solutions that are smarter, less invasive, and more personalized. To learn more about how we develop med tech that helps save lives and redefine what it feels like to be a patient, visit https://thenext.jnjmedtech.com/ | The MONARCH™ Platform is transforming medical intervention and improving patient lives. At Ethicon, we seek to leverage the power of flexible robotics to diagnose lung nodules earlier. The MONARCH™ Platform integrates a variety of technologies designed to empower physicians with greater reach, uninterrupted vision, and meticulous control to help confront the challenges they face when biopsying small, peripheral lung nodules. | As Johnson & Johnson MedTech, we are an emerging leader in neurovascular care, changing the trajectory of stroke through our portfolio of products
Intuitive Surgical
At Intuitive®, innovating for minimally invasive care is the passion that drives us. Our robotic-assisted da Vinci® Surgical System helps empower doctors and hospitals to make surgery less invasive than an open approach. | At Intuitive®, innovating for minimally invasive care is the passion that drives us. The Ion endoluminal system is Intuitive’s robotic-assisted platform for minimally invasive biopsy in the lung. We built Ion on the belief that collecting lung tissue samples for biopsy could be safe and simple, even when nodules are small and located in the peripheral lung. Ion’s ultrathin, ultramaneuverable catheter allows clinicians to reach small lesions in all 18 segments of the lung.